Latest Breaking News On - Company on track to submit - Page 1 : comparemela.com

Concluded Positive FDA Type-C Meeting in Early May 2023 Company On Track to Submit an sNDA Early in the Third Quarter of 2023 CORAL GABLES, Fla., May 09, 2023 Catalyst. | May 9, 2023

Patrickj mcenanyLambert eatonCatalyst pharmaceuticals incExchange commissionCompany on track to submitHealth canadaDrug administrationConcluded positiveEarly mayThird quarterNew drug applicationChief executive officerCatalyst pharmaceuticalsFull prescribingSafety informationFull prescribing information